Summary: “We don’t want to just get MDMA approved,” says MAPS Public Benefit Corporation (MAPS PBC) Chief Executive Officer Amy Emerson, “we want to do it in a way that tackles misinformation and stigma around mental health and psychedelics, and makes them accessible to underserved, marginalized communities.”
As part of the Women in the History of Psychedelic Plant Medicines Series, Jasmine Virdi of Chacruna Institute interviews Emerson about her personal and professional paths that led her to mission-oriented work at MAPS and MAPS PBC.
Originally appearing here.
